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SUMMARY
There is a quest for the development of a new generation of vaccines consisting of well-defined
subunit antigens. For a number of practical reasons it is attractive to develop vaccines on the basis
of synthetic peptides. However, their efficacy may be limited by genetic restrictions imposed on
T-cell recognition via major histocompatibility complex (MHC) polymorphism, as shown by many
studies using inbred animal species. To study the effect of MHC polymorphism in an outbred
species, we selected four cattle homozygous for different A-DR-DQ haplotypes, and another four
cattle which shared one haplotype in combination with a haplotype of one of the MHC
homozygous animals. We analysed responses to synthetic peptides comprising defined T-cell
epitopes of foot-and-mouth disease virus (FMDV) in this selected group of FMDV-vaccinated
cattle. This analysis shows that even in outbred animals, MHC polymorphism influences the
responses to synthetic peptides. Interestingly, one of the peptides, VP4[20-34], was recognized in
association with at least four different MHC haplotypes. Fine specificity analysis of this peptide
revealed subtle shifts in the core epitope recognized. All peptides that induced lymphocyte
proliferation in vitro were found to induce a T-helper type- 1 (Thl) type of response, irrespective of
the MHC haplotype involved. Together, these data support the notion that individuals carrying
distinct MHC types can be vaccinated successfully by vaccines that include only a limited number
of peptides. In the design of a peptide vaccine against FMDV we suggest inclusion of the highly
conserved VP4 sequence 20-34.
INTRODUCTION
One of the novel approaches in vaccine research is the
development of vaccines consisting of well-defined subunits of
pathogen-derived antigens. Most attractive is the development
of vaccines based on synthetic peptides comprising one or more
B-cell epitopes and one or more T-cell epitopes of the pathogen.
The advantages of such peptide vaccines include reduced costs
and improved safety and quality in comparison to vaccines
comprising the whole pathogen. They also comply with the
growing requirement for marker vaccines that can discriminate
between vaccinated and infected individuals. Moreover, by
peptide vaccination it is possible to manipulate the immune
system in such a manner that the production of protective
neutralizing antibodies is induced,' or that a non-responder to
native antigen is converted into a responder.2
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However, especially in the development of such peptide
vaccines, three aspects need special attention. First of all,
polymorphism in pathogen-derived proteins often occurs
in those parts of the proteins which are involved in
immune recognition. In particular, RNA viruses, including
foot-and-mouth disease virus (FMDV), contain regions
with extremely high sequence variability.3 Consequently,
T cells primed and antibodies elicited by a vaccine composed
of sequences selected from such highly variable regions of
the virus might not cross-react with virus occurring in the
field.
A second major aspect to consider is the variability of the
host immune response. A T-helper cell only recognizes an
antigenic peptide in association with one of the major histo-
compatibility complex (MHC) class II products, expressed by
antigen-presenting cells (APC).4 Each individual expresses its
own set of MHC products coded by genes with a large allelic
variation (i.e. MHC polymorphism). Hence, the MHC-
restricted T-cell response frequently implies an individual-
specific T-cell response towards peptides. This has been clearly
demonstrated in many studies in which inbred mice strains were
used.5'6
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Finally, the type of T-cell help induced by a peptide vaccine
also has to be considered. Different cytokine profiles produced
by T-helper cells lead to different effector functions.7 Again,
studies in mice suggest that the type of effector function might
also be controlled by MHC class II. In these studies a single
peptide was able to elicit different types of T-cell help in
different strains of mice.8
Here we studied the influence of MHC polymorphism on
T-cell responses to peptides after vaccination with the whole
pathogen in an outbred species, i.e. cattle. It has already been
shown that T-cell responses are under control ofMHC class II
in cattle.9-12 Extensive studies on the MHC typing of cattle
have revealed a high polymorphism comparable to that in
humans.'3 Upon detailed MHC typing of a large cattle herd,
vaccinated with whole inactivated FMDV, we were able to
select four animals homozygous for A-DR-DQ haplotypes and
four related heterozygous animals. In this way proliferative and
cytokine responses to three previously defined FMDV T-cell
epitopes14 in association with six different MHC class II (DH)
haplotypes could be examined.
MATERIALS AND METHODS
Virus
Viral antigen was prepared as described previously.14 Briefly,
FMDV strain AioHolland was grown on a baby hamster
kidney cell line (BHK21). Collected supernatant was treated
with 0-04M binary ethyleneimine to inactivate the virus, and
proteins were precipitated twice with 9% and 6% (w/v)
polyethyleneglycol (6000 MW), respectively. Intact virus was
purified on a CsCl2 equilibrium gradient. Purity was confirmed
by SDS-urea-PAGE, as described by Meloen & Briaire.i5
The preparation was dialysed against phosphate buffer
(pH 7 5), precipitated with 2 volumes of acetone at -20° and
resuspended at a concentration of mg/ml for in vitro
restimulation of bovine peripheral blood mononuclear cells
and proliferation assays.
Peptides
VP1[35-53] (IMDRFVKINSLSPTHVIDL), VP2[74-88]
(PFGHLTKLELPTDHH) and VP4[20-34] (SIINNYYMQ-
QYQNSM) were synthesized by standard solid-phase Fmoc
chemistry.'6 These peptides were purified by reversed-phase
high-performance liquid chromatography (HPLC) and the
sequence was checked by amino acid composition analysis. Ten
overlapping 15-mers, two 10-mers and one 7-mer covering the
VP4 amino acid sequence 17-40 (indicated in Table 5) were
prepared by automated simultaneous multiple peptide syn-
thesis, as described previously.14,i7 All peptides were synthe-
sized with an amide group at the C-terminus.
Animals
Eight Holstein-Friesian cows were used. These animals were
selected from the Wageningen Agricultural University (WAU)
herd, the Netherlands. Selection was based on MHC type and
family relationship. Four animals were homozygous for both
MHC class I and class II, the other four animals were MHC
heterozygous. This latter group included the four MHC class II
haplotypes of the homozygous group, plus two additional ones.
Three of the heterozygous animals had inherited the same
paternal haplotypes as three animals of the homozygous group
Table 1. Interrelationship and MHC class II haplotypes of the selected
cattle
Sire-code Sire-code Paternal Maternal
Animal no.* fathert via dam: haplotype haplotype
A1983 026B 021A DH7A§ DH7A
A2399 060A 046A DH8A DH8A
A2346 060B 035B DH22B DH22B
A2390 051A 045A DH24A DH24A
A2396 060A 18*4 DH8A DH18A
A2420 060B OllA DH22B DH7A
A2351 057B 159A DH22H DH18A
A2362 051A 159A DH24A DH18A
* Animals A1983, A2399, A2346 and A2390 were homozygous for
MHC class I and MHC class II haplotypes. Animals A2396, A2420,
A2351 and A2362 were heterozygous. Two extra DH haplotypes (22H
and 18A) were included in this latter group.
t Code number of the fathers; note that three fathers of the homo-
zygous animals were shared by three animals from the heterozygous
group.
t Code number of the sire of which the haplotype was inherited via
the mother.
§ Class II haplotype (DH), as shown in Table 2.
(Table 1). The age of the animals varied from 3 to 5 years. They
all had been vaccinated at least once with the generally used
trivalent FMDV vaccine, which is a mixture of strains
A,0Holland, OIBFS1860 and CIDetmold, and were last
revaccinated with monovalent vaccine type A, 6 months
before the start of the experiments.
MHC typing
Class II polymorphism was established by serological, bio-
chemical and DNA typing techniques. Serological typing was
performed by the two-colour fluorescence technique (TCT), as
originally described by van Rood et al.,'8 with minor
modifications as described by Nilsson et al.19 Biochemical
typing [immunoprecipitation and one-dimensional isoelectric
focusing (1D-IEF)] was performed as described by Joosten
et al.20 and Davies et al.2' The MHC class II antigens were
precipitated with 3 iil of the monoclonal antibody IL-A21 (a
gift of Dr A. J. Teale, ILRAD, Nairobi, Kenya). Molecular
typing was performed by two methods: detection of DRB3
polymorphism by polymerase chain reaction-restriction frag-
ment length polymorphism (DRB3-PCR-RFLP) and detection
ofpolymorphism ofDQA and DQB by RFLP analysis. DRB3-
PCR-RFLP typing was carried out essentially as described by
van Eijk et al.22 DQ-RFLP was performed as described by
Siguardardottir et al.23 For DQA-DQB typing, first and
second domain (exon 2 and exon 3) DQA and DQB probes
were used (clone DQA: WI, clone DQB: Yl). The sizes of
the molecular weight fragments were adjusted on the basis of
the BRL/Lifetechnologies (Baltimore, MD) 1 kb ladder. The
nomenclature used for serotyping (Dw, Dc), 1D-IEF (DRBF)
and DQA-DQB-RFLP was based on the nomenclature
proposed at the Fifth International BoLA Workshop reported
by Davies et al.24 The nomenclature used for DRB3-PCR-
RFLP was based on the one proposed by van Eijk et al.22 Based
on the combination of results of these four typing methods,
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Table 2. Defined MHC class II haplotypes (DH)
Ds DRBF DRB3 DQA DQB
DH* (serologyt) (IEFt) (PCR-RFLPt) (RFLPt) (RFLPt)
7A Dw2 02 7 2 2
8A Dwl; Dc2 06 8 12 12
18A Dwl,4; Dc7 04 18 5 5
22B Dwl; Dc9 07 22 9B 9B
22Ht Dwl, Dc9 07 22 9B 9A
24A Dw3 03 24 lA I
* Class II haplotype (DH) reference numbers, according to the Fifth
International Bovine Lymphocyte Antigen (BoLA) workshop.24
t The method of typing is shown between parentheses.
t This haplotype was not officially defined during the Fifth Inter-
national BoLA workshop. The nomenclature used is as suggested by
this workshop.24
class II haplotypes were defined. For each class II haplotype a
D-haplotype (DH) code comparable to the one introduced in
the class II report of the Fifth International BoLA Workshop24
was used (Table 2). As MHC class I and class II are strongly
linked, additional class I typing of the eight animals used in the
study and class I and class II typing of related animals further
confirmed the defined MHC class II haplotypes.
Proliferation assay
Proliferation assays were performed as described previously.'4
Briefly, peripheral blood mononuclear cells (PBMC) from the
eight FMDV-vaccinated cattle were restimulated by in vitro
incubation with 0-25pg/ml viral antigen for 7days. After an
expansion period of another 7 days in medium containing
10IU/ml recombinant human interleukin-2 (IL-2) (Sanofit,
Toulouse, France), cells were tested in a proliferation assay:
cells were incubated for 5 days in 96-well flat-bottomed tissue
culture plates (Costar, Cambridge, MA) at a concentration of
2-5 x 105 cells/ml in the presence of freshly isolated irradiated
autologous PBMC (1:1) and different concentrations of viral
antigen or peptides. All cultures were performed in triplicate.
During the last 18 hr of culture 0 4 ,Ci [3H]thymidine (specific
activity 1-0 Ci/mmol; Amersham International, Amersham, UK)
was added to each well. Incorporation of label was assessed by
liquid scintillation counting in a Betaplate-counter (Pharmacia,
Uppsala, Sweden). Results were obtained as mean c.p.m.
Cytokine assays
For measurement of interferon-y (IFN-y), IL-2 mRNA and
IL-4 mRNA, cells were pretreated as described above for the
proliferation assay. Incubations with peptides were also
performed in 96-well flat-bottomed plates (Costar) at an
equal concentration. However, to minimize contamination of
the RNA samples with RNA from APC, only adherent cells
(from 105 irradiated PBMC/well) were used as APC. After 24,
48 and 72hr of incubation with peptides, non-adherent cells
were harvested and washed with cold phosphate-buffered saline
(PBS) for RNA isolation, and supernatants were collected for
determination of IFN-y. Different dilutions of the supernatants
were assayed in duplicate for IFN-y using a commercial bovine
IFN-y EIA kit (Commonwealth Serum Laboratories, Parkville,
Table 3. Cytokine primer sequences
mRNA Strand Sequence
Actin + 5' CTGGCACGACACCTTCAACGAG 3'
- 5' AGCCAAGTCCAGACGCAGGATG 3'
IL-2 + 5' AAGTCATTGCTGCTGGA'-lAC 3'
- 5' CCTGTAGTTCCAAAACGATTCTC 3'
IL-4 + 5' GCATTGTTAGCGTCTCCTGGTAAAC 3'
- 5'C5TTCATAATCGTCT1TAGCCTTTCC 3'
+ reads 5'-3'.
- reads 3'-5'.
Victoria, Australia) according to the manufacturer's instruc-
tions. The use of this kit was described for the first time by
Rothel et al.25
Total RNA was isolated from 107 cells by the use of
RNAzolTm B (Campro Scientific, Veenendaal, the Nether-
lands) according to the manufacturer's instructions. The
amount of RNA was determined by OD260 and, if available,
10yg of each sample was checked by electrophoresis in
2% agarose/20% formaldehyde/20 mm 3-morpholino propane
sulphonic acid (MOPS)/5mm sodium acetate/I mm EDTA gel.
Three samples of 5 pg RNA were used for reverse transcriptase-
mediated synthesis of cDNA using the SuperScriptT pre-
amplification system (Gibco BRL, Paisley, UK) with oligo d(T)
as a primer, according to the manufacturer's instructions. From
each reverse transcriptase reaction mixture (volume 20 pl) 5-pl
samples were subjected to PCR. Cytokine primers were
designed from published cDNA sequences for bovine IL-226
and IL-4,27 using PC/Gene release 6.7 software (IntelliGenetics
Inc., Mountain View, CA), and were synthesized by OSWEL
DNA services (University of Edinburgh, Edinburgh, UK).
Sequences are shown in Table 3. Primers did not amplify
products from genomic DNA. Actin primers were included as a
control for quality of the cDNA product and PCR. PCR was
performed at a final concentration of 10mm Tris-HCl pH 8-3,
50mM KCl, 0-1 mg/ml gelatin, 8mm MgCl2, 02mm dNTP,
0 5 yM of the 5' and 3' primer, 2 5 U Thermus aquaticus DNA
polymerase (Taq DNA polymerase) (Gibco BRL) in a total
volume of 50 p1. The mixture was overlaid with paraffin oil
(Sigma, St Louis, MO) and then amplified using a Techne
PHC-3 thermal cycler. The amplification consisted of 30 cycles
of the following profile: denaturation at 950 for 1 min, primer
annealing at 550 for 1 min, and extension at 720 for 1 min.
Twenty-five microlitres of each PCR reaction mixture was
electrophoresed in 2% agarose gels in Tris borate/EDTA
buffer. Gels were stained with ethidium bromide and photo-
graphed. Samples were indicated positive for the relevant
product when bands of the expected size were visible.
RESULTS
In this study the influence of six bovine MHC class II
haplotypes on the proliferation and cytokine production of T
cells in response to three T-cell sites of FMDV (VP1[35-53],
VP2[74-88] and VP4[20-34]), was examined. The six MHC
class II haplotypes were present in eight cattle (Tables 1 and 2).
PBMC from these cattle were restimulated once in vitro with
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Table 4. Proliferation of PBMC from selected cattle to intact inactivated FMDV and to peptides, representing three T-cell sites of FMDV
Animal no. A1983 A2399 A2346 A2390 A2420 A2396 A2351 A2362
DH* 7A/7A 8A/8A 22B/22B 24A/24A 22B/7A 8A/18A 22H/18A 24A/18A
BGt 4547 660 1285 6438 355 8603 123 4890
Conc.
FMDV-antigent 2-5 jg/ml 42 68 17 21 122 23 57 32
VP1[35-53]§ 105 M 6-9 1-2 1 1 0 3 5-7 12 86 28
10-6M 6-6 1.1 150S5 3-0 20 62 23
10-7M 3-6 1-6 0-8 0 4 1.0 20 48 18
VP2[74-88] 10-5 M 1-8 2-0 15 0-5 303 1-3 204 2-4
106M 1-5 2-3 8-3 0-7 282 1.0 198 1-8
10-7M 1-3 1-8 4-7 0-9 75 1-8 101 1-7
VP4[20-34] 10-5M 31 66 7-1 0-4 114 8-7 151 26
10-6M 24 44 310 1.1 13 5-3 74 16
107M 17 11 2-7 1.0 4'2 3-1 27 4-3
* Class II haplotypes of the animals as shown in Table 1 and Table 2.
t BG, background proliferation of PBMC presented as c.p.m. The value obtained is the mean of 12 cultures.
t Proliferation to purified FMDV strain A10Holland presented as stimulation index (SI = proliferation to antigen/background proliferation).
§ Proliferation to three molar concentrations of the peptide indicated, also presented as SI.
Bold numbers indicate SI values of 3 0 or higher. The standard deviation of the mean was 20% or less.
purified FMDV. Thereafter, cells were incubated with each
peptide, representing one of the three T-cell sites, during which
both proliferation and cytokine production were measured.
Proliferation assays were performed using cells that were
cultured for 5 days in the presence ofdifferent concentrations of
each peptide or intact inactivated FMDV. Results are shown in
Table 4. All cattle responded very well to intact FMDV: in all
cases the stimulation index was greater than 15. Seven out of
the eight animals also responded to one or more of the peptides.
Peptide VP1[35-53] was recognized by PBMC from animals
carrying the DH7A or DH18A haplotypes. VP2[74-88] was
recognized by PBMC from animals carrying the DH22B or
DH22H haplotypes. Notably, peptide VP4[20-34] was recog-
nized by PBMC from most animals, indicating a promiscuous
recognition in association with haplotypes DH7A, DH8A,
DH22B and DH18A. The animal homozygous for the DH24A
haplotype did not recognize any of the peptides.
Apart from a clear selectivity in the responses to the
peptides, a difference in the magnitude of the responses was also
observed. Animals carrying the DH7A haplotype responded
more strongly to the VP4 than to the VP1 peptide, whereas the
opposite proved to be the case for two out of three animals
carrying the DH18A haplotype. In animals carrying the
DH22B or DH22H haplotypes, the response towards the VP2
peptide was most dominant, exceeding the response to the VP4
peptide. Similarly, the heterozygous animal A2420, typed as
DH22B/DH7A, responded to the three peptides, VP2[74-88],
VP4[20-34] and VP1[35-53], with decreasing magnitude.
Heterozygous animal A2351, typed as DH22H/DH18A,
responded strongest to VP2[74-88] due to the presence of the
DH22H haplotype. The responses to the VP1 and VP4 peptides
were more or less equally high, due to the presence of the
haplotypes DH18A and DH22H, respectively.
For refinement of the recognition of the VP4 T-cell site by
the different animals, a panel of 10 overlapping peptides, each
15 amino acids long, covering residues 17-40 of VP4, were
tested using PBMC from animals A1983 (DH7A), A2399
(DH8A) and A2362 (DH18A/DH24A). Unfortunately, we
were not able to use PBMC from animal A2346, which
excluded analysis in the context of DH22B. The results are
presented in Table 5. PBMC from animal A1983 responded to
six of the peptides, covering amino acid sequence 17-36.
Peptides covering amino acid sequence 20-39 elicited the
strongest proliferation of PBMC. from animal A2399. High
responses to all peptides, with the exception of VP4[26-40],
were found with PBMC from animal A2362. Since it was shown
that none of these peptide-specific responses was likely to occur
via the DH24A haplotype, DH18A must have been the
haplotype responsible for this effect. Deduced from these
results, three shorter peptides were synthesized and tested. As
expected, VP4[22-3 1] was recognized in association with
haplotypes DH7A and DH18A, and VP4[25-34] was recog-
nized in association with haplotypes DH8A and DH18A.
However, the 7-mer VP4[25-31] was not recognized.
Cytokine production by the PBMC following peptide-
specific stimulation was measured after 24, 48 and 72 hr
incubation with no peptide or one concentration of each
peptide. The cytokine assays were performed using PBMC
from the three homozygous cattle (A1983, A2399 and A2346),
which proliferated to one or two of the three peptides (Table 4).
Results of the IFN-y assay are shown in Table 6. IFN-y was
found in all supernatants. However, a significantly higher
concentration of IFN-y was present in 24-, 48- and 72-hr
supernatants of cells that specifically proliferated to peptide, as
shown by enhanced [3H]thymidine incorporation after 5 days
ofincubation. The presence of transcripts for IL-2 and IL-4 was
tested by PCR using specific primers. In all 24- and 72-hr
samples, IL-2 mRNA could be detected easily (data not
shown). IL-4 mRNA was not detected in any sample of cells
specifically proliferating to peptide. IL-4 mRNA was only
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Table 5. Proliferation ofPBMC to a panel of overlapping VP4 peptides
Animal no. A1983 A2399 A2362
DH 7A/7A 8A/8A 24A/18A
BG* 565 588 589
FMDV-antigent + ++ + +++
VP4 peptides
17-31 +++§ - +++
18-32 +++ - ++
19-33 +++ + +++
20-34 +++ ++ +++
21-35 +++ +++ +++
22-36 ++ +++ +++
23-37 - +++ +++
24-38 - +++ +++
25-39 - + + + +
26-40 - +
22-31 ++ - ++
25-34 - ++ ++
25-31
* BG, background proliferation of PBMC presented as c.p.m. The
value obtained is the mean of 12 cultures.
t Proliferation to 2-5 ug/ml purified FMDV strain A1oHolland.
T Proliferation to 5 x 10-5 M of the VP4 peptides. Peptide sequence
is indicated by first and last amino acid ofthe VP4 amino acid sequence.
§+++=SI>100; ++=lO<SI<100; +=3-0<SI<10; -=
SI < 3 0. (SI = stimulation index). The standard deviation ofmean was
20% or less.
clearly detectable in 48- and 72-hr samples derived from cells
proliferating non-specifically (Table 6). The enhanced IFN-y
secretion and no or decreased IL-4 transcription by cells
specifically proliferating to the peptides indicated a shift
towards a T-helper type-1 (Thl) type of response.
DISCUSSION
An attractive approach in vaccine development is the
generation of vaccines based on synthetic peptides. However,
since it is known that T cells recognize antigenic peptides only
in association with products of the polymorphic MHC,4 such a
peptide vaccine may be effective only in a selected group of
individuals. Here we studied the effect of bovine MHC class II
polymorphism on the proliferative and cytokine responses to
three T-cell sites of FMDV.
To refer to the complete MHC class II haplotype, we used
the D haplotype (DH), as defined by several typing techniques
for both the DR and DQ regions (=Ds type+ DRB3 PCR-
RFLP type + DRBF-type + DQA-RFLP type + DQB-RFLP
type). A clear correlation between the MHC class II haplotype
and the response to a particular peptide was found, which is
summarized in Table 7. Although Holstein-Friesians were
used throughout this study, D haplotypes 7A, 8A, 18A and 22B
have also been found in other breeds of cattle.24 So the three
peptides are likely to be effective in other breeds of cattle as
well. It is not certain whether the recognition of VP4[20-34] is
possible in the context of the DH22H haplotype. This
haplotype was only present in a heterozygous animal (A2351)
that also carried the DH18A haplotype, which itself is
Table 6. Proliferation, IFN-y secretion and detection of IL-4 mRNA by
or in PBMC incubated with no peptide or with each peptide, repre-
senting one of the three FMDV T-cell sites
Relative IL-4
SI* IFN-y conc.t mRNA
Incubation time (hr) 114 24 48 72 48/72
A1983$ Nopeptide 10 1.0 1 0 1 0 +
(DH7A/DH7A) VP1[35-53]§ 3-1 1F8 1-4 1-4 -
VP2[74-88] 10 10 1.0 1.0 +
VP4[20-34] 19-3 3.4 4-7 31 -
A2399 No peptide 10 10 1.0 1 0 +
(DH8A/DH8A) VP1[35-53] 1 0 1 0 09 1.0 +
VP2[74-88] 1.0 1 0 1 1 1 0 +
VP4[20-34] 7-8 2-4 3-9 3-5 -
A2346 No peptide 1.0 1 0 1 0 1.0 +
(DH22B/DH22B) VP1[35-53] 1-3 1-2 1-2 10 +
VP2[74-88] 22-2 2-7 3-5 3.1 -
VP4[20-34] 3.4 2-3 2-6 3-2 -
* Proliferation of cells was measured by a 5-day proliferation assay.
SI (stimulation indices) are shown.
t Eight times diluted supernatants of cells were tested in an IFN-y
ELISA kit. Relative IFN-y concentration was calculated as the ratio of
the OD4s0 value obtained from the supernatant and the OD4s5 value
obtained from the supernatant ofthe same cells incubated without peptide.
I Animal from which PBMC were tested with, between parentheses,
the MHC class II haplotype (DH) as shown in Table 2.
§PBMC were incubated with 10-6 M of the peptides indicated.
Bold numbers indicate SI > 3 0, OD450 ratios > 1-3 and samples in
which no IL4 mRNA was detected.
responsible for a response towards this peptide. However,
VP4[20-34] is recognized in association with the DH22B
haplotype (animal A2346) which is, with respect to DR type,
identical to the DH22H haplotype. Furthermore, the magni-
tude of the response to VP4[20-34] by PBMC from animal
A2351 was clearly enhanced compared to the response to this
peptide in the context of the DH18A haplotype only (as shown
by animal A2362). Based on both observations, we suggest that
VP4[20-34] might also be recognized in the context of the
DH22H haplotype.
The recognition of this VP4 T-cell site in the context of the
DH7A, DH8A and DH18A haplotypes was studied in more
detail. A difference in the 'core' sequences was observed for
Table 7. Association between the T-cell sites recognized by PBMC from
FMDV-vaccinated cattle and their MHC class II haplotype (DH) or
associated DRB3-PCR-RFLP type
DH DRB3-PCR-RFLP VP1[35-53] VP2[74-88] VP4[20-34]
7A 7 + - +
8A 8 - - +
18A 18 + - +
22B 22 - + +
22H 22 - + + ?
24A 24 - - -
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recognition in the context of these different haplotypes: amino
acid 22 (to 31 or less) ofVP4 was essential for recognition in the
context of the DH7A haplotype: for the DH8A haplotype,
amino acid 33 (from 26 or more) was required, although
responses increased dramatically as soon as amino acid 34 was
included; and finally, in the context of the DH18A haplotype,
the critical sequence seemed to include amino acid 25 (to 31 or
less). However, the 7-mer VP4[25-3 1] was not recognized in the
context of the DH18A haplotype. Apparently this relatively
short peptide is much less effective in MHC binding and/or
T-cell activation, as has been found in many other studies on
T-cell responses to truncated peptides.28'29 Another possibility
is that in the context of the DH18A haplotype more than one
'core' sequence within the VP4 sequence 17-39 is present, one
within region 22-31 and the other within region 25-34, each
binding to the same or to different MHC class II molecules (e.g.
DR and DQ). These kinds of shifts in 'core' sequences within
one promiscuous T-cell site of an antigen have been described
before.30 Analysis of such a T-cell site indicated that the peptide
assumed different conformations upon interaction with dif-
ferent MHC molecules.31
We did not observe a significant shift in cytokine profiles of
PBMC that were derived from animals carrying different MHC
class II haplotypes, but that proliferated to the same peptide.
Similarly, no differences in cytokine profiles of PBMC that
were derived from a single animal but that specifically
proliferated to different peptides could be found. PBMC that
specifically proliferated to peptide were all found to secrete
more IFN-y and less IL-4 than non-specifically proliferating
cells, indicating a shift towards T-helper cells of the Thl
subtype upon peptide-specific stimulation.7
We do not know whether the responses to the FMDV
peptides, reported here, are restricted via DR, DQ or maybe
even other products expressed from the bovine MHC class II
32,3region. Evidence of DR and/or DQ restriction might be
obtained by testing other MHC-typed cattle matched either for
DR or DQ. However, selection of such animals will not be easy,
since DQ and DR are in strong linkage disequilibrium.3435
Alternatively, the use of blocking DR- and DQ-specific
monoclonal antibodies (mAb) or direct MHC-peptide bind-
ing assays could be informative in this matter. However, well-
defined mAb are currently unavailable for these studies.
Knowledge of the precise restriction element is not
necessarily essential for the prediction of the effectiveness of a
peptide in a MHC-typed animal. Cross-overs between the
different MHC class II loci appear to be limited, leading to a
strong linkage between DR, DQ and probably also other
products.34'35 Thus, in general, typing for only one MHC class
II product might be sufficient to predict the outcome of the
response towards a peptide. Although about 600 animals of the
WAU herd are typed for DRB3 by PCR-RFLP, only a few
animals are typed for the complete MHC class II haplotype. If
we consider our findings for this population of 600 animals, the
following predictions can be made with regard to the successful
implementation of peptide vaccines (for this purpose the
DRB3-PCR-RFLP types, associated with the DH haplotypes
studied so far, are included in Table 7). Complete non-
responsiveness to the three FMDV peptides was observed for
the DH24A haplotype. Seventeen animals in the typed WAU
herd were found to be homozygous for DRB3*24, a DRB3 type
which is found to occur exclusively in the DH24A haplotype.
Thus, only 3% of non-responders from the total herd of 600
animals would be expected, on the basis of the frequency of the
DH24A haplotype. To date, 32 DRB3-PCR-RFLP types have
been defined. So far, four of these have been shown to be
associated with a response to VP4[20-34]. Yet, 60% of the
WAU herd was positive for one or two of these four responder
DRB3-PCR-RFLP types. If the distribution of class II
haplotypes is representative for the Holstein-Friesian breed
in general, VP4[20-34] would be a good candidate for inclusion
in a peptide vaccine, especially since this site is derived from a
highly conserved region of the virus as well. The amino acid
sequence of VP4[20-34] is 100% identical between serotypes A,
0 and C of FMDV. An effective synthetic vaccine might be
generated for example by coupling the VP4 T-cell site in
combination with one or more B-cell epitopes to the
lipotripeptide (P3CSS), as studied by Wiesmuller et al.36 or by
inclusion of the peptides into liposomes.37
In conclusion, these findings show for the first time that a
strong MHC-restricted selection of T-cell epitopes also occurs
in an outbred population like cattle. This will have major
implications for research on vaccine development, and for the
design of synthetic vaccines in particular. The influence of
MHC polymorphism may be less apparent in the response to
complete viral proteins. Still, the effect ofMHC polymorphism
must not be under-estimated when testing new subunit vaccines
in randomly chosen groups of animals. In order to establish the
efficacy of the vaccine in different MHC backgrounds, the
animals used should be typed in advance. Then groups of
animals can be selected in which the most frequent MHC class
II types are represented and equally distributed. For the
development of a peptide vaccine, MHC polymorphism will
surely have an influence, as we have shown here. In order to
design a peptide vaccine which is effective in all animals, the
response to different T-cell epitopes should be tested for all
possible MHC haplotypes. For this kind of study homozygous
animals are indispensable. Finally, a combination of a limited
number of peptides, covering a T-cell response in association
with all haplotypes should be included in the vaccine. The
present study shows that for this purpose conserved and
promiscuous epitopes of a complex pathogen like FMDV can
be found that largely circumvent the MHC-related restriction
even in an outbred population.
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